최종기 조교수
#간질환
|
학력
2017 .03 ~ 2019 .02울산대학교 의학 박사
경력
2020 .03 ~ 현재서울아산병원 소화기내과 조교수
2019 .03 ~ 2020 .02서울아산병원 소화기내과 촉탁임상조교수
2016 .07 ~ 2019 .02서울아산병원 소화기내과 전임의
2015 .06 ~ 2016 .06Presence St. Francis Hospital Internal Medicine Resident
2014 .10 ~ 2015 .06Mayo Clinic Research Fellow
2011 .04 ~ 2014 .04안동시보건소 공중보건의
2007 .03 ~ 2011 .02서울아산병원 내과 전공의
2019 .03 ~ 2020 .02서울아산병원 소화기내과 촉탁임상조교수
2016 .07 ~ 2019 .02서울아산병원 소화기내과 전임의
2015 .06 ~ 2016 .06Presence St. Francis Hospital Internal Medicine Resident
2014 .10 ~ 2015 .06Mayo Clinic Research Fellow
2011 .04 ~ 2014 .04안동시보건소 공중보건의
2007 .03 ~ 2011 .02서울아산병원 내과 전공의
논문
Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.
Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population.
Lamivudine: fading into the mists of time.
Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.
Reply.
Risks versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients
Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population.
Lamivudine: fading into the mists of time.
Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.
Reply.
Risks versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients
저서
저서 내용이 없습니다.
보도자료
'노벨상'이 주목한 C형간염… 무증상으로 간암 불러
https://health.chosun.com/site/data/html_dir/2020/10/06/2020100602085.html
같은 B형간염약 다른 간암발생률...국내이어 홍콩서도 확인
http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125821&REFERER=NP
[노벨상 시즌] “C형 간염 바이러스 규명으로 95% 이상 치료 가능해져”
http://www.inews24.com/view/1304548
https://health.chosun.com/site/data/html_dir/2020/10/06/2020100602085.html
같은 B형간염약 다른 간암발생률...국내이어 홍콩서도 확인
http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125821&REFERER=NP
[노벨상 시즌] “C형 간염 바이러스 규명으로 95% 이상 치료 가능해져”
http://www.inews24.com/view/1304548
포스팅
Possible Role of Surgery in the Treatment of Patients with Intermediate Stage Hepatocellular Carcinoma and Preserved Hepatic Function
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.